ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

July 30, 2004

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

Agreement Reached On Most CCOP Issues; First RFA To Be Out March, Awards To Be Made In Fiscal 1983

January 22, 1982

NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition

April 18, 1986

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992